As Halliburton Co Com (HAL) Market Valuation Declined, Zeke Capital Advisors Has Decreased Its Position; Gilead Sciences (GILD) Shareholder Finemark National Bank & Trust Has Raised Its Position by $3.21 Million

April 20, 2018 - By Kurt Siggers

Halliburton Company (NYSE:HAL) Logo

Zeke Capital Advisors Llc decreased its stake in Halliburton Co Com (HAL) by 31.7% based on its latest 2017Q4 regulatory filing with the SEC. Zeke Capital Advisors Llc sold 6,913 shares as the company’s stock declined 2.35% with the market. The hedge fund held 14,895 shares of the oilfield services and equipment company at the end of 2017Q4, valued at $728,000, down from 21,808 at the end of the previous reported quarter. Zeke Capital Advisors Llc who had been investing in Halliburton Co Com for a number of months, seems to be less bullish one the $45.66 billion market cap company. The stock increased 0.31% or $0.16 during the last trading session, reaching $52.17. About 6.73 million shares traded. Halliburton Company (NYSE:HAL) has declined 1.88% since April 20, 2017 and is downtrending. It has underperformed by 13.43% the S&P500.

Finemark National Bank & Trust increased its stake in Gilead Sciences Inc (GILD) by 341.82% based on its latest 2017Q4 regulatory filing with the SEC. Finemark National Bank & Trust bought 45,277 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 58,523 shares of the health care company at the end of 2017Q4, valued at $4.19 million, up from 13,246 at the end of the previous reported quarter. Finemark National Bank & Trust who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $95.76 billion market cap company. The stock decreased 1.34% or $1 during the last trading session, reaching $73.44. About 2.43 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 20, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. As per Wednesday, October 4, the company rating was maintained by Bank of America. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Argus Research on Monday, November 13. The company was maintained on Thursday, May 26 by Morgan Stanley. The firm has “Hold” rating given on Thursday, February 22 by Leerink Swann. On Tuesday, January 16 the stock rating was upgraded by Wells Fargo to “Outperform”. Citigroup maintained the shares of GILD in report on Friday, April 29 with “Buy” rating. The company was initiated on Friday, February 5 by Leerink Swann. The firm has “Buy” rating given on Thursday, September 22 by Berenberg. Jefferies maintained the stock with “Buy” rating in Wednesday, October 5 report. The stock has “Buy” rating by Standpoint Research on Wednesday, February 3.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It is negative, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Whittier Trust Company has invested 0.42% in Gilead Sciences, Inc. (NASDAQ:GILD). Commercial Bank Of Hawaii stated it has 42,382 shares. Dana Advisors Inc reported 26,851 shares. Atwood & Palmer Inc invested in 226,778 shares. Kcm Advsr Ltd Liability Company owns 8,761 shares. Tarbox Family Office Inc accumulated 6,554 shares or 0.19% of the stock. Cetera Advisor Limited Liability Com invested in 32,847 shares or 0.1% of the stock. Ionic Mgmt Lc reported 0.07% stake. Atlantic Gp Limited Liability Corporation holds 169,582 shares. Krensavage Asset Management Llc reported 478,053 shares or 10.68% of all its holdings. Commerzbank Aktiengesellschaft Fi invested 0.37% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Quantitative Systematic Strategies Lc, a Connecticut-based fund reported 6,350 shares. Endurance Wealth Management accumulated 0.28% or 24,010 shares. Artemis Invest Mgmt Llp holds 101,939 shares. Domini Impact Ltd reported 5.9% in Gilead Sciences, Inc. (NASDAQ:GILD).

Finemark National Bank & Trust, which manages about $1.57B US Long portfolio, decreased its stake in Vanguard Intl Equity Index F (VWO) by 9,649 shares to 32,151 shares, valued at $1.48 million in 2017Q4, according to the filing. It also reduced its holding in Allergan Plc by 2,410 shares in the quarter, leaving it with 2,432 shares, and cut its stake in Adobe Sys Inc (NASDAQ:ADBE).

Since January 2, 2018, it had 0 buys, and 17 sales for $39.51 million activity. Cogan John Francis also sold $437,067 worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Monday, April 2. 60,000 shares valued at $4.68M were sold by WILSON GAYLE E on Friday, February 9. $401,566 worth of stock was sold by Washington Robin L on Wednesday, February 21. The insider Alton Gregg H sold 30,000 shares worth $2.37 million. Meyers James R sold $8.02 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, January 16.

Analysts await Halliburton Company (NYSE:HAL) to report earnings on April, 23 before the open. They expect $0.41 earnings per share, up 925.00% or $0.37 from last year’s $0.04 per share. HAL’s profit will be $358.81 million for 31.81 P/E if the $0.41 EPS becomes a reality. After $0.53 actual earnings per share reported by Halliburton Company for the previous quarter, Wall Street now forecasts -22.64% negative EPS growth.

Investors sentiment increased to 1.15 in Q4 2017. Its up 0.30, from 0.85 in 2017Q3. It improved, as 54 investors sold HAL shares while 283 reduced holdings. 125 funds opened positions while 261 raised stakes. 675.47 million shares or 0.60% less from 679.57 million shares in 2017Q3 were reported. First Tru Advsrs LP reported 9,738 shares. Jennison Associates Limited Company, a New York-based fund reported 8.86M shares. Schroder Management Grp holds 365,705 shares or 0.03% of its portfolio. Williams Jones Limited Com owns 21,009 shares. Adell Harriman Carpenter Inc reported 0.17% of its portfolio in Halliburton Company (NYSE:HAL). Livforsakringsbolaget Skandia Omsesidigt accumulated 0.06% or 13,212 shares. Perella Weinberg Cap Management LP reported 180,466 shares stake. Oakworth Cap stated it has 2,897 shares or 0.03% of all its holdings. 200,000 were reported by Encompass Capital Advsr Limited Liability Company. Klingenstein Fields & Ltd Limited Liability Company holds 0.04% or 19,860 shares in its portfolio. Fred Alger Mngmt reported 2.31M shares. Moreover, Lazard Asset Management Lc has 0.02% invested in Halliburton Company (NYSE:HAL). 45,915 are held by Highland Capital Limited Liability. Polaris Greystone Gp Ltd Co reported 4,620 shares. Johnson Counsel owns 8,887 shares.

Since January 2, 2018, it had 0 insider buys, and 10 sales for $8.39 million activity. Brown James S had sold 12,977 shares worth $713,475. McKeon Timothy also sold $251,835 worth of Halliburton Company (NYSE:HAL) shares. 39,287 shares were sold by Voyles Robb L., worth $2.16 million on Monday, January 22. Beaty Anne L. also sold $151,459 worth of Halliburton Company (NYSE:HAL) shares. On Monday, January 22 the insider Miller Jeffrey Allen sold $1.60 million.

Halliburton Company (NYSE:HAL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts